|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/56 | (2006.01) |
| A61K 31/56 | (2013.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 5/24 | (2018.01) | ||
| A61P 7/00 | (2018.01) |
| (11) | Patento numeris | 3653213 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19199484.7 |
| Europos patento paraiškos padavimo data | 2014-10-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-05-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-02-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361887643 P | 2013-10-07 | US |
| (72) |
WOTTON, Paul K. , US
JAFFE, Jonathan , US
|
| (73) |
Antares Pharma, Inc. ,
100 Princeton South
Corporate Center
Suite 300, Ewing, New Jersey 08628,
US
|
| (54) | HEMATOCRIT MODULATION THROUGH NEEDLE ASSISTED JET INJECTION OF TESTOSTERONE |
| HEMATOCRIT MODULATION THROUGH NEEDLE ASSISTED JET INJECTION OF TESTOSTERONE |